These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15810751)

  • 21. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis.
    Cohen SP; Dawson TC
    Pediatrics; 2002 Sep; 110(3):e38. PubMed ID: 12205288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients.
    Takeyasu M; Miyamoto A; Kato D; Takahashi Y; Ogawa K; Murase K; Mochizuki S; Hanada S; Uruga H; Takaya H; Morokawa N; Kishi K
    Intern Med; 2016; 55(7):725-9. PubMed ID: 27041155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids?
    Clemens KE; Quednau I; Klaschik E
    J Palliat Med; 2008 Mar; 11(2):204-16. PubMed ID: 18333735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute respiratory depression as a complication of nebulised morphine.
    Lang E; Jedeikin R
    Can J Anaesth; 1998 Jan; 45(1):60-2. PubMed ID: 9466030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world opioid prescription to patients with serious, non-malignant, respiratory illnesses and chronic breathlessness.
    Chen X; Moran T; Smallwood N
    Intern Med J; 2022 Nov; 52(11):1925-1933. PubMed ID: 35384242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study.
    Martins RT; Currow DC; Abernethy AP; Johnson MJ; Toson B; Eckert DJ
    Respirology; 2016 Feb; 21(2):386-91. PubMed ID: 26560987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Ogawa T; Watanabe F; Arizono S
    Respir Med; 2007 Apr; 101(4):833-8. PubMed ID: 16962758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Dose Morphine for Dyspnea in Terminally Ill Patients with Idiopathic Interstitial Pneumonias.
    Matsuda Y; Maeda I; Tachibana K; Nakao K; Sasaki Y; Sugimoto C; Arai T; Tokoro A; Akira M; Inoue Y
    J Palliat Med; 2017 Aug; 20(8):879-883. PubMed ID: 28437202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
    Clemens KE; Klaschik E
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
    Clemens KE; Klaschik E
    J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids prescription for symptoms relief and the impact on respiratory function: updated evidence.
    López-Saca JM; Centeno C
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):383-90. PubMed ID: 25319272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease.
    Janahi IA; Maciejewski SR; Teran JM; Oermann CM
    Pediatr Pulmonol; 2000 Sep; 30(3):257-9. PubMed ID: 10973044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
    Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
    J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioids, Exertion, and Dyspnea: A Review of the Evidence.
    Johnson MJ; Hui D; Currow DC
    Am J Hosp Palliat Care; 2016 Mar; 33(2):194-200. PubMed ID: 25294225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
    Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
    Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating dyspnea with morphine sulfate in nonverbal children with neurological impairment.
    Hauer JM
    Pediatr Pulmonol; 2015 Apr; 50(4):E9-12. PubMed ID: 25470003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease.
    Poole PJ; Veale AG; Black PN
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1877-80. PubMed ID: 9620921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.
    Abernethy AP; Currow DC; Frith P; Fazekas BS; McHugh A; Bui C
    BMJ; 2003 Sep; 327(7414):523-8. PubMed ID: 12958109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral morphine drops for prompt relief of breathlessness in patients with advanced cancer-a randomized, double blinded, crossover trial of morphine sulfate oral drops vs. morphine hydrochloride drops with ethanol (red morphine drops).
    Aabom B; Laier G; Christensen PL; Karlsson T; Jensen MB; Hedal B
    Support Care Cancer; 2020 Jul; 28(7):3421-3428. PubMed ID: 31792878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.